208 related articles for article (PubMed ID: 18563594)
1. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
[TBL] [Abstract][Full Text] [Related]
2. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
Christopherson KW; Hangoc G; Broxmeyer HE
J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
[TBL] [Abstract][Full Text] [Related]
3. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
Christopherson KW; Cooper S; Broxmeyer HE
Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
5. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
6. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
Wang J; Shiozawa Y; Wang J; Wang Y; Jung Y; Pienta KJ; Mehra R; Loberg R; Taichman RS
J Biol Chem; 2008 Feb; 283(7):4283-94. PubMed ID: 18057003
[TBL] [Abstract][Full Text] [Related]
7. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
Li H; Wang YS
Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
[TBL] [Abstract][Full Text] [Related]
8. SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26.
Hildebrandt M; Schabath R
Front Biosci; 2008 Jan; 13():1774-9. PubMed ID: 17981666
[TBL] [Abstract][Full Text] [Related]
9. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E
Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827
[TBL] [Abstract][Full Text] [Related]
10. CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion.
Havre PA; Abe M; Urasaki Y; Ohnuma K; Morimoto C; Dang NH
Br J Cancer; 2009 Sep; 101(6):983-91. PubMed ID: 19654580
[TBL] [Abstract][Full Text] [Related]
11. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
12. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
18. CD26/dipeptidyl peptidase IV and its role in cancer.
Pro B; Dang NH
Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776
[TBL] [Abstract][Full Text] [Related]
19. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
Narducci MG; Scala E; Bresin A; Caprini E; Picchio MC; Remotti D; Ragone G; Nasorri F; Frontani M; Arcelli D; Volinia S; Lombardo GA; Baliva G; Napolitano M; Russo G
Blood; 2006 Feb; 107(3):1108-15. PubMed ID: 16204308
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
